The FDA creates a quicker path for gene therapies

NPR·Feb 23

This story is reported by NPR. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

WTAS: FDA Launches Framework for Accelerating Development of Individualized Therapies for Ultra-Rare Diseases

HHS.gov·Feb 25

2

US FDA proposes framework to speed rare disease gene therapy approvals

Reuters·Feb 23

3

Gene Editing for Human Therapies Just Got a Shortcut: What the FDA’s New Draft Guidance Means for Your Business

ArentFox Schiff·Jun 12

4

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency

CNBC·Jun 17

5

Understanding FDA's Plausible Mechanism Framework For Genetic Medicines

Life Science Leader·Jun 19

6

Potentially “groundbreaking” FDA gene therapy pathway leaves key issues unresolved

Clinical Trials Arena·Dec 1

7

Celebrating a new, faster path to gene-editing medicines on demand

STAT·Nov 14

8

FDA moves to facilitate personalized therapies for rare diseases

Washington Examiner·Feb 23